JULIUS CLINICAL – SCIENCE CONTRACT RESEARCH ORGANISATION
GLOBAL & FOCUSED
Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world. Our unique combination of scientific leadership and operational excellence ensures that the trial data is of the highest quality.
We specialise in distinct therapeutic areas including Cardio Metabolic, Infectious diseases and Immunology and Brain. We can offer a full-service proposal or separate functional services as required.
ENT CLINICAL
The academic clinical research organisation with the expertise to support your clinical development program in the hearing field.
RWE & RWD
Julius Clinical’s RWE specialists and data scientists are academic thought leaders in RWE, RWD and the creation of tailor-made studies.
I/I
Julius Clinical’s experience in infectious disease research is epitomized by the CAPiTA study; the largest vaccine trial worldwide.
CARDIO METABOLIC
Julius Clinical has a strong track record of expertise and performance in the field of Cardiovascular diseases and the related field Metabolic diseases.
BRAIN
Julius Clinical is active in the field of diseases affecting the Brain, managing trials involving patients with a range of neurological or psychiatric disorders.
One of the great challenges in clinical trials is to identify the right patients and to minimize inclusion failures. In the recent paper by van Dijk and co-workers in close collaboration with Professor Diederick (Rick) E. Grobbee, MD, PhD, FESC from UMC Utrecht and Julius Clinical, a novel strategy was evaluated.
Manuel Castro Cabezas provided his commentary on
the paper and raised the question: Could this strategy may also be applied for NASH Clinical trials? You can read his full commentary ‘How to improve patient inclusion in NASH trials: Lessons from cardiovascular outcome trials’ on our Nash Clinical website. https://lnkd.in/dabEH_M
You will also find a link to download the paper: Text-mining in electronic healthcare records can be used as efficient tool for screening and data collection in cardiovascular trials: a multicentre validation study.